Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rangering i aksjer #27034
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Aksjekurs
$2.21
Markedsverdi
$35.76M
Endring (1 dag)
2.88%
Endring (1 år)
-15.27%
Land
PL
Handel Mabion S.A. (MAB)

Kategori

Historikk for aksjesplitt for Mabion S.A. (MAB)
Aksjen Mabion S.A. (symbol: MAB) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én MAB-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 MAB-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH